SEC Form 4 · accession 0001493152-18-005769
Advaxis, Inc. · ADXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andres Gutierrez
Officer — Exec VP, Chief Medical Officer
Period of report
Apr 25, 2018
Accepted (ET)
Apr 25, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100397
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF1 | $1.62 | Apr 23, 2018 | A | 250,000 | A | Apr 23, 2019 | Apr 23, 2028 | Common stock | 250,000 | 250,000 | D |
Explanation of responses
- F1Awarded as an inducement grant of stock options pursuant to the reporting person's employment agreement dated April 23, 2018. One-third of the award will vest on April 23, 2019, one-third will vest on April 23, 2020, and the award will be fully vested on April 23, 2021.